Health In Tech, Inc. (HIT) · Oct 26, 2026 · Exec change

Health In Tech CEO change adds execution focus, equity hurdles

CEO transition — Sanjay Shrestha replaces founder Tim Johnson as CEO

Health In Tech’s CEO change puts operations under Sanjay Shrestha while founder Tim Johnson stays involved; the equity package ties rewards to growth milestones.

Health In Tech is an AI-enabled insurance marketplace trying to turn its HitRix platform and carrier relationships into broader commercial adoption; its recent operating challenge is execution and scale, not simply product creation.

The transition separates founder vision from day-to-day execution. Sanjay Shrestha becomes CEO while founder Tim Johnson moves to Executive Chairman, leaving Johnson focused on strategy, technology and product development while Shrestha owns operating performance, commercial execution and potential acquisitions. 〔0〕

The incentive package is designed around a much larger growth story, but it is not evidence that the growth has arrived. The filing grants or proposes up to 8 million shares across sign-on, acquisition and market-capitalization awards, with milestones ranging from a market capitalization above $150 million by April 30, 2028, to above $1 billion by December 31, 2031. The largest unissued tranches depend on shareholder approval, and the structure creates meaningful potential dilution if those hurdles are ultimately met. 〔1〕

This does not yet prove a turnaround or resolve the company’s governance pressure. The filing supplies no new revenue, profitability or operating target, and its own risk disclosure still identifies the need to regain and maintain Nasdaq compliance; that matters because Nasdaq recently notified Health In Tech that it was out of compliance with board-independence and audit-committee requirements.

The news itself is mostly confirmation, not a fresh surprise. The CEO appointment and founder transition were announced effective October 20, 2026, six days before this 8-K was filed, so the filing mainly adds the employment and equity-award mechanics rather than changing the leadership narrative. 〔2〕

Bottom line: This is a planned management reshuffle aimed at converting Health In Tech’s technology platform into commercial growth, with founder continuity preserved. It improves accountability for execution but is not, by itself, operating proof—and the shareholder vote makes the equity package the immediate next test.

What to watch next

Shareholder vote on equity-plan expansion, November 10, 2026

Original filing on SEC EDGAR

More Health In Tech, Inc. news

Health In Tech CEO change adds execution focus, equity hurdles | HIT Stock News
AllSight

Breaking down Wall Street's
information edge.

A buy-side analyst on every ticker — it reads every public company's filing the instant it drops and decodes it into plain English.

—
8-K events this week
—
filings analyzed in total
live · updated 30s ago
Live events · whole market · · --:--:-- ET
AllSight read
Straight from the 8-K
Verbatim from the filing AllSight decoded — highlighted above. Open on SEC EDGAR ↗
Limited-time offerFree 14-day Pro trial
AllSight

Sign in to AllSight

  • Follow any company — we email you the moment it files, free!
  • Your watchlist saved to your account, on every device — free!

by Signing in NOW, claim your FREE 14-day Pro trial!

No password. We email you a 6-digit code. By continuing you agree to our Terms & Privacy.
AllSight · Live plain-English 8-K decodes across the whole US market · Not investment advice.